These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7827162)

  • 1. Epidemiology, prevention, and early detection of breast cancer.
    Helzlsouer KJ
    Curr Opin Oncol; 1994 Nov; 6(6):541-8. PubMed ID: 7827162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, early detection, and prevention of breast cancer.
    Helzlsouer KJ
    Curr Opin Oncol; 1993 Nov; 5(6):955-9. PubMed ID: 8305544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, prevention, and early detection of breast cancer.
    Helzlsouer KJ
    Curr Opin Oncol; 1995 Nov; 7(6):489-94. PubMed ID: 8547394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen for prevention of breast cancer.
    Cersosimo RJ
    Ann Pharmacother; 2003 Feb; 37(2):268-73. PubMed ID: 12549959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
    Vogel VG
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s. PubMed ID: 11916233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial.
    Cuzick J; Forbes JF; Sestak I; Cawthorn S; Hamed H; Holli K; Howell A;
    J Natl Cancer Inst; 2007 Feb; 99(4):272-82. PubMed ID: 17312304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity.
    Chlebowski RT; Haque R; Hedlin H; Col N; Paskett E; Manson JE; Kubo JT; Johnson KC; Wactawski-Wende J; Pan K; Anderson G
    Breast Cancer Res Treat; 2015 Dec; 154(3):609-16. PubMed ID: 26602222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of breast cancer.
    Osborne MP
    Surg Clin North Am; 1999 Oct; 79(5):1207-21. PubMed ID: 10572559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Breakthrough in breast cancer chemoprevention].
    Kahán Z; Thurzó L
    Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, prevention, and early detection of breast cancer.
    Alberg AJ; Visvanathan K; Helzlsouer KJ
    Curr Opin Oncol; 1998 Nov; 10(6):492-7. PubMed ID: 9818226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study.
    Veronesi U; Maisonneuve P; Costa A; Sacchini V; Maltoni C; Robertson C; Rotmensz N; Boyle P
    Lancet; 1998 Jul; 352(9122):93-7. PubMed ID: 9672273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of the main outcomes in breast-cancer prevention trials.
    Cuzick J; Powles T; Veronesi U; Forbes J; Edwards R; Ashley S; Boyle P
    Lancet; 2003 Jan; 361(9354):296-300. PubMed ID: 12559863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors for the treatment and prevention of breast cancer.
    Kalidas M; Brown P
    Clin Breast Cancer; 2005 Apr; 6(1):27-37. PubMed ID: 15899070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk-benefit profiles of women using tamoxifen for chemoprevention.
    Nichols HB; DeRoo LA; Scharf DR; Sandler DP
    J Natl Cancer Inst; 2015 Jan; 107(1):354. PubMed ID: 25475563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer risks and prevention: implications of the Breast Cancer Prevention Trial results.
    Crowell EB; Jubelirer SJ
    W V Med J; 2000; 96(6):598-601. PubMed ID: 11194088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.
    Fisher B; Costantino JP; Redmond CK; Fisher ER; Wickerham DL; Cronin WM
    J Natl Cancer Inst; 1994 Apr; 86(7):527-37. PubMed ID: 8133536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition.
    Chlebowski RT; Col N; Winer EP; Collyar DE; Cummings SR; Vogel VG; Burstein HJ; Eisen A; Lipkus I; Pfister DG;
    J Clin Oncol; 2002 Aug; 20(15):3328-43. PubMed ID: 12149307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
    Brewster AM; Christo DK; Lai H; Helzlsouer K
    Cancer; 2005 Mar; 103(6):1147-53. PubMed ID: 15674856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, prevention, and early detection of breast cancer.
    Daudt A; Alberg AJ; Helzlsouer KJ
    Curr Opin Oncol; 1996 Nov; 8(6):455-61. PubMed ID: 8971464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.